An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...
In the announcement, FDA Commissioner Mackary said, “Bayesian methodologies help address two of the biggest problems of drug development: high costs and long timelines. Providing clarity around modern ...
A research team of Specially Appointed Associate Professor Harrison B. Smith of Earth-Life Science Institute (ELSI) at ...
BOSTON--(BUSINESS WIRE)--d-wise (an Instem company), a leader in statistical computing infrastructure and clinical trial transparency, today announced the appointment of Christine Oliver as its ...
This first systematic review on Quality by Design (QbD) in nanocosmetics analyzed 52 original articles, identifying particle size (94.2%), polydispersity index (76.9%), and zeta potential (75%) as the ...
A study found a machine learning model more accurately predicted major adverse cardiac events, such as heart attacks, than ...
The traditional gold standard of clinical trials with a randomized, placebo-controlled design involving hundreds of patients ...
Atropos Health, the pioneer in translating real-world clinical data into personalized real-world evidence (RWE) for clinical ...
Physicists have shown how time can effectively be reversed for some quantum systems, which would allow for new ways to ...
In this work, the authors demonstrated that blue light mediated mitochondrial contacts attenuated blue light induced mitochondrial dysfunction, and validated this in human cells and C. elegans. This ...
Atropos Health, the world's largest creator of real-world evidence (RWE) for clinical decision making, today announced the availability of the largest source of novel medical content - with over 33M ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results